Metabolomics
188,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
94 °P sammeln
  • Broschiertes Buch

Metabolomics: A Path Towards Personalized Medicine integrates environmental factors of genomics, transcriptomics and proteomics, providing a bridge to resolve gaps between fundamental science and applications in clinical medicine and population health. The concept of personalized medicine or precision medicine is of great interest in biomedical research as it helps bring about new drug discovery and biomarker identification. In addition, it helps clinicians prescribe the right medicine to the right person with maximum efficacy and minimum toxicity, allowing clinicians to further predict the…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Metabolomics: A Path Towards Personalized Medicine integrates environmental factors of genomics, transcriptomics and proteomics, providing a bridge to resolve gaps between fundamental science and applications in clinical medicine and population health. The concept of personalized medicine or precision medicine is of great interest in biomedical research as it helps bring about new drug discovery and biomarker identification. In addition, it helps clinicians prescribe the right medicine to the right person with maximum efficacy and minimum toxicity, allowing clinicians to further predict the susceptibility to disease onset of vulnerable populations. The book is ideally suited for researchers and postgraduate students who are interested in clinical and non-clinical studies where metabolites are used for the identification of disease and therapeutic targets.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr. Mahbuba Rahman earned her B.Sc. (Honors) and M. Sc in Microbiology and an M.S in Environmental Science. She obtained her PhD in Metabolic Engineering from the Department of Bioscience and Bioinformatics, Kyushu Institute of Technology, Japan. Post PhD, she worked with transgenic mice model of Smith-Lemli-Opitz syndrome, which is an inborn error of cholesterol synthesis, at Children's Hospital Research Institute (CHORI), Oakland, California. She is involved with multiple translational projects including identification of biomarkers for colon cancer and application of phage display technology in clinical research to investigate immune response against different viral species in primary immunodeficient patients, association of virus infection and obesity, and role of stress responsive genes in pathogenic bacteria. Mahbuba has published several research articles in high impact factor journals. She also authored multiple review articles and book chapters in high impact factor journals and with well-known publishers. She is also an editor of an eBook on cancer immunotherapy and special topic editor and guest editor in Frontiers in Genetics.